Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1991
10/30/1991CN1055732A Novel alpha-mannosidase and fucosidase inhibitors
10/30/1991CN1055665A Use of anti-progestomimetic compounds in breeding animals
10/30/1991CN1014528B Process for producing compounds of the kind of cephalosporin
10/30/1991CN1014521B Process for the preparation of forms of nedocromil sodium and pharmaceutical formulation
10/30/1991CN1014519B Process for preparation of 5-naphthyl-2, 4-dialkyl-3h-1, 2, 4-triazoie-3-thiones and their use as antidepressants
10/30/1991CN1014516B Phenyl ethers
10/30/1991CN1014515B Nonaromatic fluoroallylamine mao inhibitors
10/30/1991CN1014492B Prepn for pyrido-pyridine o-acetyl-salicylic or their pharmaceutical salt compatible products and use
10/30/1991CA2041422A1 .alpha.-glycosyl naringin, and its preparation and uses
10/29/1991WO1991017116A1 Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
10/29/1991US5061813 Substituted cyanoimino benzopyranes
10/29/1991US5061806 Phosphinic acid derivatives
10/29/1991US5061804 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives and processes for the preparation thereof
10/29/1991US5061803 Process for making 17-beta alkanoyl 3-oxo-4-aza-5-α-androst-1-enes
10/29/1991US5061802 17β-aminobenzoyl-4-aza-5α-androst-1-en-3-ones as benign prostatic hypertrophy agents
10/29/1991US5061801 Intermediate for making 3-oxo-4-aza-androst-1-ene 17β-ketones
10/29/1991US5061800 Camptothecin derivatives
10/29/1991US5061787 Novel spergualin-related compounds and compositions
10/29/1991US5061734 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
10/29/1991US5061733 Tetrahydronaphthalene and indane compounds useful for reversing the photodamage in sun-exposed skin
10/29/1991US5061730 Inhibitors of dehydropeptidase and renal dipeptidase; prevent unnecessary hydrolysis of beta-lactam ring of carbapenem antib iotics
10/29/1991US5061728 Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of inflammation and as immunosuppressants
10/29/1991US5061727 Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
10/29/1991US5061725 Cognition activators
10/29/1991US5061724 Applying mixture of absorbable skin cream and indomethcin placed in a bandage to skin area
10/29/1991US5061722 Hypotensive agents; e.g. ramipril
10/29/1991US5061721 Side effect reduction
10/29/1991US5061718 Benzothiazolylmethoxy compounds, pharmaceutical compositions comprising the same and their use as anti-inflammatory or anti-allergenic agents
10/29/1991US5061717 Anticholesterol agents
10/29/1991US5061715 Prevention of glycoprotein enveloped virus infectivity by quinolyl- and isoquinolyloxazole-2-zones
10/29/1991US5061714 Isoquinoline composition for the treatment of glaucoma or ocular hypertension
10/29/1991US5061713 No antiinflammatory activity
10/29/1991US5061712 Bactericides
10/29/1991US5061711 Method of curing liver diseases by using pyrrolo quinoline quinone triesters and novel pyrrolo quinoline quinone triesters
10/29/1991US5061710 Mercapto-acylamino acid antihypertensives
10/29/1991US5061706 2,3-quinoxalinediones for use as neuroleptics
10/29/1991US5061705 Skin disorders
10/29/1991US5061704 Pathologies involving loss of bone tissue
10/29/1991US5061703 Alzheimer*s disease
10/29/1991US5061702 Cephem compound as an antimicrobial agent
10/29/1991US5061701 Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
10/29/1991US5061699 Compounds effective in inducing cell differentiation and process for preparing same
10/29/1991US5061696 Hypotonic compositions for selectively killing undesirable lens cells in the human eye and methods for using such compositions
10/29/1991US5061694 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
10/29/1991US5061493 Galenical forms of corticoids for administration perlingually and sublingually and process for their preparation
10/29/1991US5061486 Dithranol composition containing no oily ingredients
10/29/1991US5061484 Polymerized unsaturated phospholipid coatings on perfluorochemical particles; synthetic blood
10/29/1991US5061477 Use of cobalt to enhance urinary copper excretion
10/29/1991CA2081351A1 1-(2h-1-oxo-3, 4-dihydronaphtyl-6) -acetyl-piperidines, process for their preparation and therapeutic use
10/29/1991CA2040940A1 5-(1,2,4-triazol-1-ylmethyl)-isoxazolines
10/29/1991CA1291486C Quaternary ammonium salts possessing antimicrobial activity and methods for preparation and use thereof
10/29/1991CA1291484C 6-substituted-4-dialkylaminotetrahydrobenz¬c,d|indoles
10/29/1991CA1291483C Process for the preparation of encainide and an intermediate therefor
10/29/1991CA1291479C Piperazihyl-l-pyrimidine derivatives, their preparation and their application in drugs and cosmetics
10/29/1991CA1291478C Pyridazodiazepine derivatives
10/28/1991WO1991017161A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists
10/28/1991WO1991017157A1 Gamma-butyrolactol ether derivatives
10/28/1991WO1991017153A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use
10/28/1991WO1991016819A1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein
10/28/1991WO1991000092A1 Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
10/28/1991CA2081350A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists
10/28/1991CA2081204A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use
10/28/1991CA2080346A1 Gamma-butyrolactol ether derivatives
10/28/1991CA2041163A1 Heterocyclic derivatives : 2-styryl-4h-1-benzopyran-4-ones; process for preparing the same and pharmaceutical compositions containing them
10/28/1991CA2040866A1 Antimicrobial compositions and process for preparing the same
10/28/1991CA2040855A1 Cytotoxic bicyclo¬7.3.1| tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
10/28/1991CA2039789A1 Calicheamicinone, derivatives and analogs thereof and methods of making the same
10/27/1991WO1991016058A1 Composition and method for topical treatment of damaged or diseased tissue
10/27/1991WO1991016035A1 Chelator compositions comprising alpha-diamine compounds
10/27/1991WO1991016034A1 Chelator compositions comprising oxime compounds
10/27/1991CA2081340A1 Composition and method for topical treatment of damaged or diseased tissue
10/27/1991CA2041175A1 Carboxylic acid derivatives
10/26/1991WO1991016314A1 Pyridazinone derivative
10/26/1991WO1991016049A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof
10/26/1991CA2081346A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof
10/25/1991WO1991016325A1 Heterocyclic compounds and their preparation and use
10/25/1991WO1991016320A1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/25/1991CA2081201A1 Heterocyclic compounds and their preparation and use
10/24/1991WO1992017189A1 Gangliosides with immunosuppressive activity
10/24/1991WO1991016888A1 Spiro[benzofurancycloalkane]carboxamides as 5ht3 antagonists
10/24/1991WO1991016067A1 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
10/24/1991DE4012894A1 Compsns. contg. carnitine and fish oil - for preventing and treating fat metabolism disorders, esp. hyperlipidaemia
10/24/1991CA2081023A1 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
10/24/1991CA2081011A1 Spiro[benzofurancycloalkane]carboxamides as 5ht3 antagonists
10/24/1991CA2040885A1 Substituted benzhydryl 2-hydroxypropyl piperazine derivatives
10/24/1991CA2039742A1 Tablet composition and method for problem pharmaceutical materials
10/23/1991EP0453365A1 Process for the preparation of 1-(2,3,4-trimethoxybenzyl) piperazine by reductive amination
10/23/1991EP0453337A2 Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmic use
10/23/1991EP0453288A1 Enantiospecific synthesis of S(+)-5,6-dihydro-4-(R-amino)-4H thieno (2,3-B)thiopyran-2-sulfonamide-7,7-dioxide
10/23/1991EP0453242A1 Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
10/23/1991EP0453210A2 Pyridine derivatives
10/23/1991EP0453197A1 Amine derivatives
10/23/1991EP0453195A1 (S)-alkyl 3-(thien-2-ylthio) butyrate and analogs and synthesis thereof
10/23/1991EP0453127A2 Treatment of cataract with 15-keto-prostaglandin compounds
10/23/1991EP0453042A1 Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones
10/23/1991EP0453018A2 Poly (alpha-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions
10/23/1991EP0453001A1 Pharmaceutical composition for the targeted controlled release of an active principle within the intestine, and particularly within the colon
10/23/1991EP0452987A1 Isoindoline derivatives
10/23/1991EP0452941A2 Use of isomonools in the treatment and prophylaxis of cancer
10/23/1991EP0452935A1 Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
1 ... 7316 7317 7318 7319 7320 7321 7322 7323 7324 7325 7326 7327 7328 7329 7330 7331 7332 7333 7334 7335 7336 ... 7860